.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Merck
Accenture
Cantor Fitzgerald
Moodys
Dow
Colorcon
Argus Health
US Department of Justice

Generated: December 18, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Details for Patent: ► Subscribe

Title: Acyl deoxyribonucleoside derivatives and uses thereof
Abstract:The invention relates to compositions comprising acyl derivatives of 2'-deoxyribonucleosides. The invention also relates to methods of treating or preventing radiation, mutagen and sunlight-induced biological damage, and methods for improving wound healing and tissue repair, comprising administering the compositions of the present invention to an animal.
Inventor(s): von Borstel; Reid Warren (Darnestown, MD), Bamat; Michael Kevin (Darnestown, MD)
Assignee: Pro-Neuron, Inc. (N/A)
Filing Date:Jun 07, 1995
Application Number:08/479,516
Claims:1. A method of enhancing the delivery of exogenous 2'-deoxyadenosine to the tissue of an animal, comprising the step of administering to said animal of an acyl derivative of 2'-deoxyadenosine, having the formula ##STR19##

wherein R.sub.1, R.sub.2 and R.sub.3 are the same or different and each of H or an acyl group derived from a carboxylic acid, provided that at least one of R.sub.1, R.sub.2 and R.sub.3 is not hydrogen.

2. A method as in claim 1 wherein R.sub.1, R.sub.2, and R.sub.3 are the same or different and each is hydrogen or an acyl group derived from

(a) an unbranched fatty acid with 2 to 22 carbon atoms,

(b) an amino acid selected from the group consisting of glycine, the L forms of alanine, valine, leucine, isoleucine, tyrosine, proline, hydroxyproline, serine, threonine, cysteine, aspartic acid, glutamic acid, arginine, lysine, histidine, carnitine, and ornithine,

(c) nicotinic acid, or

(d) a dicarboxylic acid having 3 to 22 carbon atoms, provided that not all of R.sub.1, R.sub.2, and R.sub.3 are H, or a pharmaceutically acceptable salt thereof.

3. A method as in claim 2 wherein R.sub.1, R.sub.2 and R.sub.3 are the same or different and each is H or an acyl group derived from an unbranched fatty acid with 2 to 22 carbon atoms.

4. A method as in claim 3 wherein R.sub.1 and R.sub.2 are fatty acids with 6 to 16 carbon atoms.

5. A method of enhancing the delivery of exogenous 2'-deoxyguanosine to the tissue of an animal, comprising the step of administering to said animal an acyl derivative of 2'-deoxyguanosine having the formula ##STR20##

wherein R.sub.1, R.sub.2 and R.sub.3 are the same or different and each is H or an acyl group derived from a carboxylic acid, provided that at least one of R.sub.1, R.sub.2 and R.sub.3 is not hydrogen.

6. A method as in claim 5 wherein R.sub.1, R.sub.2, and R.sub.3 are the same or different and each is hydrogen or an acyl group derived from

(a) an unbranched fatty acid with 2 to 22 carbon atoms,

(b) an amino acid selected from the group consisting of glycine, the L forms of alanine, valine, leucine, isoleucine, tyrosine, proline, hydroxyproline, serine, threonine, cysteine, aspartic acid, glutamic acid, arginine, lysine, histidine, phenylalanine, carnitine, and ornithine,

(c) nicotinic acid, or

(d) a dicarboxylic acid having 3 to 22 carbon atoms, provided that not all of R.sub.1, R.sub.2, and R.sub.3 are H, or a pharmaceutically acceptable salt thereof.

7. A method as in claim 2 wherein R.sub.1, R.sub.2 and R.sub.3 are the same or different and each is H or an acyl group derived from an unbranched fatty acid with 2 to 22 carbon atoms.

8. A method as in claim 3 wherein R.sub.1 and R.sub.2 are fatty acids with 6 to 16 carbon atoms.

9. A method of enhancing the delivery of exogenous 2'-deoxycytidine to the tissue of an animal, comprising the step of administering to said animal an acyl derivative of 2'-deoxycytidine, having the formula ##STR21##

wherein R.sub.1, R.sub.2 and R.sub.3 are the same or different and each is H or an acyl group derived from a carboxylic acid, provided that at least one of R.sub.1, R.sub.2 and R.sub.3 is not hydrogen.

10. A method as in claim 9 wherein R.sub.1, R.sub.2, and R.sub.3 are the same or different and each is hydrogen or an acyl group derived from

(a) an unbranched fatty acid with 2 to 22 carbon atoms,

(b) an amino acid selected from the group consisting of glycine, the L forms of alanine, valine, leucine, isoleucine, tyrosine, proline, hydroxyproline, serine, threonine, cysteine, aspartic acid, glutamic acid, arginine, lysine, histidine, carnitine, and ornithine,

(c) nicotinic acid, or

(d) a dicarboxylic acid having 3 to 22 carbon atoms, provided that not all of R.sub.1, R.sub.2, and R.sub.3 are H, or a pharmaceutically acceptable salt thereof.

11. A method as in claim 2 wherein R.sub.1, R.sub.2 and R.sub.3 are the same or different and each is H or an acyl group derived from an unbranched fatty acid with 2 to 22 carbon atoms.

12. A method as in claim 3 wherein R.sub.1 and R.sub.2 are fatty acids with 6 to 16 carbon atoms.

13. A method of enhancing the delivery of exogenous 2'-deoxythymidine to the tissue of an animal, comprising the step of administering to said animal an acyl derivative of 2'-deoxythymidine, having the formula ##STR22##

wherein R.sub.1 is an acyl group derived from

(a) an unbranched fatty acid with 2 to 15 or 17 to 22 carbon atoms,

(b) an amino acid selected from the group consisting of glycine, the L forms of alanine, valine, leucine, isoleucine, tyrosine, proline, hydroxyproline, serine, threonine, cysteine, aspartic acid, glutamic acid, arginine, lysine, histidine, carnitine, and ornithine,

(c) nicotinic acid, or

(d) a dicarboxylic acid having 3 to 22 carbon atoms, or a pharmaceutically acceptable salt thereof.

14. A method as in claim 13 wherein R.sub.1 is an unbranched fatty acid with 2 to 15 or 17 to 22 carbon atoms.

15. A method as in claim 14 wherein R.sub.1 is an unbranched fatty acid with 2 to 4 carbon atoms.

16. A method of enhancing the delivery of exogenous 2'-deoxythymidine to the tissue of an animal, comprising the step of administering to said animal an acyl derivative of 2'-deoxythymidine, having the formula ##STR23##

wherein R.sub.2 is an acyl group derived from

(a) an unbranched fatty acid with 2 to 13 or 15 to 22 carbon atoms,

(b) an amino acid selected from the group consisting of glycine, the L forms of alanine, valine, leucine, isoleucine, tyrosine, proline, hydroxyproline, serine, threonine, cysteine, aspartic acid, glutamic acid, arginine, lysine, histidine, carnitine, and ornithine,

(c) nicotinic acid, or

(d) a dicarboxylic acid with 3 to 22 carbon atoms, or a pharmaceutically acceptable salt thereof.

17. A method as in claim 16 wherein R.sub.2 is an unbranched fatty acid with 2 to 13 or 15 to 22 carbon atoms.

18. A method as in claim 17 wherein R.sub.2 is an unbranched fatty acid with 2 to 4 carbon atoms.

19. A method of enhancing the delivery of exogenous 2'-deoxythymidine to the tissue of an animal, comprising the step of administering to said animal an acyl derivative of 2'-deoxythymidine, having the formula ##STR24##

wherein R.sub.1 and R.sub.2 are the same or different and each is an acyl group derived from

(a) an unbranched fatty acid with 2 to 22 carbon atoms,

(b) an amino acid selected from the group consisting of glycine, the L forms of alanine, valine, leucine, isoleucine, tyrosine, proline, hydroxyproline, serine, threonine, cysteine, aspartic acid, glutamic acid, arginine, lysine, histidine, carnitine, and ornithine,

(c) nicotinic acid, or

(d) a dicarboxylic acid with 3 to 22 carbon atoms, or a pharmaceutically acceptable salt thereof.

20. A method as in claim 19 wherein R.sub.1 and R.sub.2 are the same or different and each is an unbranched fatty acid with 2 to 22 carbon atoms.

21. A method as in claim 20 wherein R.sub.1 and R.sub.2 are the same or different and each is an unbranched fatty acid with 2 to 4 carbon atoms.

22. A method of enhancing the delivery of exogenous 2'-deoxythymidine to the tissue of an animal, comprising the step of administering to said animal an acyl derivative of 2'-deoxythymidine, having the formula ##STR25##

wherein R.sub.1 and R.sub.2 are the same or different and each is an acyl group derived from

(a) an unbranched fatty acid with 2 to 22 carbon atoms,

(b) an amino acid selected from the group consisting of glycine, the L forms of alanine, valine, leucine, isoleucine, tyrosine, proline, hydroxyproline, serine, threonine, cysteine, aspartic acid, glutamic acid, arginine, lysine, histidine, carnitine, and ornithine,

(c) nicotinic acid, or

(d) a dicarboxylic acid with 3 to 22 carbon atoms, and R.sub.3 is an acyl group derived from an optionally substituted benzoyl or heterocyclic acid that is substantially nontoxic, or a pharmaceutically acceptable salt thereof.

23. A method as in claim 22 wherein R.sub.1 and R.sub.2 are the same or different and each is an unbranched fatty acid with 2 to 22 carbon atoms.

24. A method as in claim 23 wherein R.sub.1 and R.sub.2 are the same or different and each is an unbranched fatty acid with 2 to 4 carbon atoms.

25. A method as in claim 23 wherein R.sub.3 is an acyl group derived from nicotinic acid, benzoic acid, or para-aminobenzoic acid.
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Healthtrust
Julphar
Cantor Fitzgerald
Accenture
Baxter
Farmers Insurance
Federal Trade Commission
Covington
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot